CABA
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Cellares and Cabaletta Bio signed a 10-year commercial supply agreement to scale rese-cel productionApr 28, 2026
- Cabaletta Bio obtained IND amendment clearance for Rese-Cel manufacturing using Cellares platformsJan 12, 2026
- Cabaletta Bio anticipates 2027 BLA submission for Rese-cel in myositis following FDA alignment on registrational cohorts.May 15, 2025